08 Dec THE GENESIGHT STUDY: Integrating Genetic Profiles into Clinical Care for Dementia
WHAT IS THE PURPOSE OF THIS STUDY?
To measure the impact of results from genetic testing on medication symptoms and dementia care.
WHO IS ELIGIBLE?
Individuals between the ages of 65-97, who live in either assisted living or skilled care, are on certain medications, and who have dementia with psychotic symptoms.
WHAT DO THEY NEED TO DO?
1. Call The Samuel and Alexia Bratton Memory Clinic, at 410-820-5191, to schedule a screening appointment.
2. Come in for a screening visit and for a cheek swab for DNA sampling.
3. Participate in up to 3 follow up visits to collect information on medications and memory.
4. Receive compensation for your time and effort
WHO IS CONDUCTING THIS STUDY?
A company called Assurex is funding this study in partnership with the The Samuel & Alexia Bratton Memory Clinic